Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma (Q38893243)

7 September 2017

title

Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma (English)

1 reference

7 September 2017

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Marina Colombi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

Stefania Maria Filomena Mitola

7 June 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Roberto Ronca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Luca Madaro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Marina Bouché

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Pietro Luigi Poliani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Marika Vezzoli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Eugenio Monti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Davide Maggi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Fiorella Faggi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Francesca Longhena

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Barbara Salani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Charles Keller

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

Alessandro Fanzani

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

publication date

30 March 2015

1 reference

7 September 2017

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

585-602

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25822667 AND SRC:MED&resulttype=core&format=json

Myogenic tumors in children and adolescents

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Mechanisms of impaired differentiation in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Rhabdomyosarcomas: an overview on the experimental animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Effects of RAS on the genesis of embryonal rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Lineage of origin in rhabdomyosarcoma informs pharmacological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

A mouse model of rhabdomyosarcoma originating from the adipocyte lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Sarcomas across the age spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

The insulin-like growth factor system and sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Loss of suppressor-of-fused function promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Dystrophin is a tumor suppressor in human cancers with myogenic programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolae as plasma membrane sensors, protectors and organizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

21 January 2018

The caveolin proteins

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolae: from cell biology to animal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

The multiple faces of caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Exploring the caves: cavins, caveolins and caveolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Cavin proteins: New players in the caveolae field

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Constitutive formation of caveolae in a bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolins in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PKCθ signaling is required for myoblast fusion by regulating the expression of caveolin-3 and β1D integrin upstream focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Development of resistance to vincristine in a childhood rhabdomyosarcoma growing in immune‐deprived mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

A specific chromosomal abnormality in rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Toxicity determined in vitro by morphological alterations and neutral red absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Neutral red uptake assay for the estimation of cell viability/cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Stem cells in the hood: the skeletal muscle niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Cell stress is related to re-localization of Argonaute 2 and to decreased RNA interference in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

The transcript release factor PTRF augments ribosomal gene transcription by facilitating reinitiation of RNA polymerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

A 60-kDa protein abundant in adipocyte caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Association and insulin regulated translocation of hormone-sensitive lipase with PTRF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Polymerase I and Transcript Release Factor Regulates Lipolysis via a Phosphorylation-Dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Pleiotropic effects of cavin-1 deficiency on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Down‐regulation of the cavin family proteins in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF/cavin-1 is essential for multidrug resistance in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolin-1 in oncogenic transformation, cancer, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveats of caveolin-1 in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolin-1 in tumor progression: the good, the bad and the ugly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolin-1 in sarcomas: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Caveolin and cavin family members: dual roles in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Polymerase I and transcript release factor (PTRF)/cavin-1 is a novel regulator of stress-induced premature senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Regulation of cellular senescence by the essential caveolar component PTRF/Cavin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2015.45

PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters

21 January 2018

1 reference

12 December 2020

Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells

1 reference

12 December 2020

Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models

1 reference

12 December 2020

Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.

1 reference

12 December 2020

Lipodystrophy and muscular dystrophy caused by PTRF mutations

1 reference

12 December 2020

Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.

1 reference

12 December 2020

Genetic modeling of human rhabdomyosarcoma

1 reference

12 December 2020

New genetic tactics to model alveolar rhabdomyosarcoma in the mouse

1 reference

12 December 2020

Vanadium compounds affect growth and morphology of human rhabdomyosarcoma cell line.

1 reference

12 December 2020

Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations

1 reference

12 December 2020

Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma

1 reference

12 December 2020

Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling.

1 reference

12 December 2020

Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein

1 reference

12 December 2020

Cavin fever: regulating caveolae

1 reference

12 December 2020